MNPR
Monopar Therapeutics Inc
NASDAQ: MNPR · HEALTHCARE · BIOTECHNOLOGY
$110.26
+0.27% today
Updated 2026-09-11
Market cap
$795.73M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.24
Dividend yield
—
52W range
$41 – $125
Volume
0.2M
Monopar Therapeutics Inc (MNPR) Insider transactions
Net insider activity
Net selling (82,176 shares)
Buy transactions
54
Sell transactions
46
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-08-26 | TSUCHIMOTO, KIM R | Director | Buy | 2,055 | — | — |
| 2026-08-26 | TSUCHIMOTO, KIM R | Director | Buy | 2,035 | — | — |
| 2026-08-26 | TSUCHIMOTO, KIM R | Director | Buy | 2,055 | $30.00 | $61650.00 |
| 2026-08-26 | TSUCHIMOTO, KIM R | Director | Buy | 2,035 | $14.00 | $28490.00 |
| 2026-08-26 | TSUCHIMOTO, KIM R | Director | Sale | 1,098 | $111.84 | $122800.32 |
| 2026-08-26 | TSUCHIMOTO, KIM R | Director | Sale | 700 | $110.65 | $77455.00 |
| 2026-08-26 | TSUCHIMOTO, KIM R | Director | Sale | 615 | $109.56 | $67379.40 |
| 2026-08-26 | TSUCHIMOTO, KIM R | Director | Sale | 602 | $112.93 | $67983.86 |
| 2026-08-26 | TSUCHIMOTO, KIM R | Director | Sale | 590 | $113.84 | $67165.60 |
| 2026-08-26 | TSUCHIMOTO, KIM R | Director | Sale | 485 | $108.83 | $52782.55 |
| 2026-08-26 | RIOUX, PATRICE | Acting Chief Medical Officer | Buy | 1,380 | — | — |
| 2026-08-26 | RIOUX, PATRICE | Acting Chief Medical Officer | Buy | 1,380 | $0.01 | $6.90 |
| 2026-08-26 | RIOUX, PATRICE | Acting Chief Medical Officer | Sale | 1 | $111.26 | $111.26 |
| 2026-08-25 | ANDERSON, RAYMOND | Director | Buy | 1,740 | — | — |
| 2026-08-25 | ANDERSON, RAYMOND | Director | Buy | 1,402 | — | — |
| 2026-08-25 | ANDERSON, RAYMOND | Director | Sale | 1,802 | $113.05 | $203716.10 |
| 2026-08-25 | ANDERSON, RAYMOND | Director | Buy | 1,740 | $30.00 | $52200.00 |
| 2026-08-25 | ANDERSON, RAYMOND | Director | Buy | 1,402 | $30.00 | $42060.00 |
| 2026-08-25 | ANDERSON, RAYMOND | Director | Sale | 694 | $110.04 | $76367.76 |
| 2026-08-25 | ANDERSON, RAYMOND | Director | Sale | 646 | $111.07 | $71751.22 |
| 2026-06-30 | VU, QUAN ANH | Chief Financial Officer | Sale | 1,228 | — | — |
| 2026-06-30 | VU, QUAN ANH | Chief Financial Officer | Buy | 1,228 | — | — |
| 2026-06-30 | VU, QUAN ANH | Chief Financial Officer | Sale | 507 | $92.59 | $46943.13 |
| 2026-06-30 | ROBINSON, CHANDLER | Director, Chief Executive Officer | Sale | 12,873 | — | — |
| 2026-06-30 | ROBINSON, CHANDLER | Director, Chief Executive Officer | Buy | 12,873 | — | — |
| 2026-06-30 | ROBINSON, CHANDLER | Director, Chief Executive Officer | Sale | 4,084 | $92.59 | $378137.56 |
| 2026-06-30 | CITTADINE, ANDREW | Chief Operating Officer | Sale | 5,254 | — | — |
| 2026-06-30 | CITTADINE, ANDREW | Chief Operating Officer | Buy | 5,254 | — | — |
| 2026-06-30 | CITTADINE, ANDREW | Chief Operating Officer | Sale | 2,309 | $92.59 | $213790.31 |
| 2026-06-26 | SWEENY, NICOLE | Director | Buy | 1,284 | — | — |
| 2026-03-31 | ROBINSON, CHANDLER | Director, Chief Executive Officer | Sale | 6,732 | — | — |
| 2026-03-31 | ROBINSON, CHANDLER | Director, Chief Executive Officer | Buy | 6,732 | — | — |
| 2026-03-31 | ROBINSON, CHANDLER | Director, Chief Executive Officer | Sale | 1,972 | $54.79 | $108045.88 |
| 2026-03-31 | CITTADINE, ANDREW | Chief Operating Officer | Sale | 3,514 | — | — |
| 2026-03-31 | CITTADINE, ANDREW | Chief Operating Officer | Buy | 3,514 | — | — |
| 2026-03-31 | CITTADINE, ANDREW | Chief Operating Officer | Sale | 1,571 | $54.79 | $86075.09 |
| 2026-03-02 | RODRIGUEZ, SUSAN | CCSO | Buy | 48,728 | — | — |
| 2026-01-01 | RIOUX, PATRICE | Acting Chief Medical Officer | Buy | 2,000 | — | — |
| 2025-12-31 | ROBINSON, CHANDLER | Director, Chief Executive Officer | Sale | 8,724 | — | — |
| 2025-12-31 | ROBINSON, CHANDLER | Director, Chief Executive Officer | Buy | 8,724 | — | — |
| 2025-12-31 | ROBINSON, CHANDLER | Director, Chief Executive Officer | Sale | 2,558 | $65.30 | $167037.40 |
| 2025-12-31 | CITTADINE, ANDREW | Chief Operating Officer | Sale | 4,326 | — | — |
| 2025-12-31 | CITTADINE, ANDREW | Chief Operating Officer | Buy | 4,326 | — | — |
| 2025-12-31 | CITTADINE, ANDREW | Chief Operating Officer | Sale | 1,889 | $65.30 | $123351.70 |
| 2025-12-26 | VU, QUAN ANH | Chief Financial Officer | Buy | 1,500 | $69.95 | $104925.00 |
| 2025-12-18 | KLAUSNER, ARTHUR J | Director | Sale | 4,660 | $67.06 | $312499.60 |
| 2025-12-18 | KLAUSNER, ARTHUR J | Director | Sale | 461 | $68.09 | $31389.49 |
| 2025-12-16 | KLAUSNER, ARTHUR J | Director | Buy | 7,710 | — | — |
| 2025-12-16 | HENDRICKS, DIANE | 10% Owner | Sale | 43,499 | — | — |
| 2025-12-02 | VU, QUAN ANH | Chief Financial Officer | Buy | 7,135 | — | — |
| 2025-12-02 | VU, QUAN ANH | Chief Financial Officer | Buy | 9,826 | — | — |
| 2025-12-02 | TSUCHIMOTO, KIM R | Director | Buy | 2,924 | — | — |
| 2025-12-02 | TALUKDAR, LAVINA | Director | Buy | 2,924 | — | — |
| 2025-12-02 | STARR, CHRISTOPHER M | Director | Buy | 2,924 | — | — |
| 2025-12-02 | ROBINSON, CHANDLER | Director, Chief Executive Officer | Buy | 16,753 | — | — |
| 2025-12-02 | ROBINSON, CHANDLER | Director, Chief Executive Officer | Buy | 49,133 | — | — |
| 2025-12-02 | KLAUSNER, ARTHUR J | Director | Buy | 2,924 | — | — |
| 2025-12-02 | CITTADINE, ANDREW | Chief Operating Officer | Buy | 8,969 | — | — |
| 2025-12-02 | CITTADINE, ANDREW | Chief Operating Officer | Buy | 13,919 | — | — |
| 2025-12-02 | ANDERSON, RAYMOND | Director | Buy | 2,924 | — | — |
| 2025-09-30 | ROBINSON, CHANDLER | Director, Chief Executive Officer | Sale | 8,726 | — | — |
| 2025-09-30 | ROBINSON, CHANDLER | Director, Chief Executive Officer | Buy | 8,726 | — | — |
| 2025-09-30 | ROBINSON, CHANDLER | Director, Chief Executive Officer | Sale | 2,646 | $81.67 | $216098.82 |
| 2025-09-30 | CITTADINE, ANDREW | Chief Operating Officer | Sale | 4,327 | — | — |
| 2025-09-30 | CITTADINE, ANDREW | Chief Operating Officer | Buy | 4,327 | — | — |
| 2025-09-30 | CITTADINE, ANDREW | Chief Operating Officer | Sale | 1,896 | $81.67 | $154846.32 |
| 2025-09-24 | TACTIC, PHARMA LLC | 10% Owner | Sale | 550,229 | $63.61 | $35.00M |
| 2025-07-14 | TSUCHIMOTO, KIM R | Director | Sale | 4,704 | — | — |
| 2025-07-14 | TSUCHIMOTO, KIM R | Director | Sale | 4,200 | — | — |
| 2025-07-14 | TSUCHIMOTO, KIM R | Director | Buy | 8,904 | $0.01 | $44.52 |
| 2025-07-14 | STARR, CHRISTOPHER M | Director | Sale | 16,800 | — | — |
| 2025-07-14 | STARR, CHRISTOPHER M | Director | Buy | 16,800 | $0.01 | $84.00 |
| 2025-07-14 | ROBINSON, CHANDLER | Director, Chief Executive Officer | Sale | 16,800 | — | — |
| 2025-07-14 | ROBINSON, CHANDLER | Director, Chief Executive Officer | Buy | 16,800 | $0.01 | $84.00 |
| 2025-06-30 | ROBINSON, CHANDLER | Director, Chief Executive Officer | Sale | 13,344 | — | — |
| 2025-06-30 | ROBINSON, CHANDLER | Director, Chief Executive Officer | Buy | 13,344 | — | — |
| 2025-06-30 | ROBINSON, CHANDLER | Director, Chief Executive Officer | Sale | 5,865 | $35.78 | $209849.70 |
| 2025-06-30 | CITTADINE, ANDREW | Chief Operating Officer | Sale | 6,863 | — | — |
| 2025-06-30 | CITTADINE, ANDREW | Chief Operating Officer | Buy | 6,863 | — | — |
| 2025-06-30 | CITTADINE, ANDREW | Chief Operating Officer | Sale | 2,990 | $35.78 | $106982.20 |
| 2025-04-02 | TACTIC, PHARMA LLC | 10% Owner | Sale | 33,334 | $35.00 | $1.17M |
| 2025-03-31 | ROBINSON, CHANDLER | Director, Chief Executive Officer | Sale | 4,106 | — | — |
| 2025-03-31 | ROBINSON, CHANDLER | Director, Chief Executive Officer | Buy | 4,106 | — | — |
| 2025-03-31 | ROBINSON, CHANDLER | Director, Chief Executive Officer | Sale | 1,204 | $36.41 | $43837.64 |
| 2025-03-31 | CITTADINE, ANDREW | Chief Operating Officer | Buy | 1,791 | — | — |
| 2025-03-31 | CITTADINE, ANDREW | Chief Operating Officer | Sale | 744 | $36.41 | $27089.04 |
| 2025-03-04 | TSUCHIMOTO, KIM R | Director | Buy | 11,365 | — | — |
| 2025-03-04 | TALUKDAR, LAVINA | Director | Buy | 5,683 | — | — |
| 2025-03-04 | STARR, CHRISTOPHER M | Director | Buy | 11,365 | — | — |
| 2025-03-04 | ROBINSON, CHANDLER | Director, Chief Executive Officer | Buy | 85,759 | — | — |
| 2025-03-04 | ROBINSON, CHANDLER | Director, Chief Executive Officer | Buy | 79,899 | — | — |
| 2025-03-04 | ROBINSON, CHANDLER | Director, Chief Executive Officer | Sale | 6,002 | — | — |
| 2025-03-04 | ROBINSON, CHANDLER | Director, Chief Executive Officer | Buy | 6,002 | — | — |
| 2025-03-04 | ROBINSON, CHANDLER | Director, Chief Executive Officer | Sale | 1,759 | $31.70 | $55760.30 |
| 2025-03-04 | KLAUSNER, ARTHUR J | Director | Buy | 11,365 | — | — |
| 2025-03-04 | CITTADINE, ANDREW | Chief Operating Officer | Buy | 43,445 | — | — |
| 2025-03-04 | CITTADINE, ANDREW | Chief Operating Officer | Buy | 40,581 | — | — |
| 2025-03-04 | ANDERSON, RAYMOND | Director | Buy | 11,365 | — | — |
| 2025-03-03 | VU, QUAN ANH | Chief Financial Officer | Buy | 25,000 | — | — |
| 2025-01-28 | ROBINSON, CHANDLER | Director, Chief Executive Officer | Buy | 62,815 | — | — |
Frequently asked questions
Are MNPR insiders buying or selling?
Over the transactions on record, MNPR insiders have been net buyers, with about $39.26M in stock sold across 46 sales, against 9 open-market purchases.
Does insider selling at MNPR mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which MNPR insiders are selling the most?
Recent selling is concentrated in a few names. TACTIC, PHARMA LLC accounts for the largest share on record, with about $36.17M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.